Discover 306 paid clinical trials in Santa Fe, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 306
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Albuquerque NM, Tucson AZ, Phoenix AZ, Oklahoma City OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Albuquerque NM, Lubbock TX, El Paso TX, Denver CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Albuquerque NM, Lubbock TX, El Paso TX, Denver CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Albuquerque NM, Tucson AZ, Oklahoma City OK,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase2, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Albuquerque NM, Abilene TX, Salt Lake City UT,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Albuquerque NM, Tucson AZ, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Albuquerque NM, Lubbock TX, El Paso TX, Denver CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Albuquerque NM, Phoenix AZ, Tucson AZ, Hays KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Albuquerque NM, Amarillo TX, Tucson AZ, Hays KS,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Albuquerque NM, Durango CO, Pueblo CO,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase2, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Location: Albuquerque NM, Lubbock TX, El Paso TX, Denver CO,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 22
Code: NCT04726241
Phase1, Phase2, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for
Pancreatic Acinar Cell Carcinoma,
Location: Albuquerque NM, Hays KS, Kingman AZ, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04858334
Phase2, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Albuquerque NM, Lubbock TX, El Paso TX, Denver CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer